Indication
Hepatic Veno-Occlusive Disease
1 clinical trial
1 product
Clinical trial
A Phase II Intrapatient Open-Label Dose Escalation Trial of Defibrotide in Hematopoietic Cell Transplantation (HCT) Recipients With Sinusoidal Obstructive Syndrome (SOS) Post-HCT Associated With Either Renal and/or Pulmonary Dysfunction With Either Refractory or Progressive Disease Following Defibrotide TherapyStatus: Recruiting, Estimated PCD: 2026-08-01
Product
Defibrotide